These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36164556)

  • 41. Detection rate of pustules in palmoplantar pustulosis with dermoscopy.
    Nakanishi T; Kokubu H; Fujimoto N; Tanaka T
    J Dermatol; 2022 Feb; 49(2):299-302. PubMed ID: 34723401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pyoderma gangrenosum and suppurative hidradenitis association, overlap or spectrum of the same disease? Case report and discussion.
    Turcu G; Ioana Nedelcu R; Teodora Nedelcu I; Hodorogea A; Balaban M; Brinzea A; Nichita L; Gabriela Popp C; Andrada Zurac S; Theodor Andrei R
    Exp Ther Med; 2020 Jul; 20(1):38-41. PubMed ID: 32508990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful Management of Anti-TNF-Induced Psoriasis Despite Continuation of Therapy in a Pyoderma Gangrenosum Patient.
    Toussi A; Le ST; Barton VR; Ma C; Cheng MY; Sukhov A; Wilken R; Patel F; Wang E; Maverakis E
    J Drugs Dermatol; 2020 Feb; 19(2):199-201. PubMed ID: 32129973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Jumihaidokuto (Shi-Wei-Ba-Du-Tang), a Kampo Formula, Decreases the Disease Activity of Palmoplantar Pustulosis.
    Mizawa M; Makino T; Inami C; Shimizu T
    Dermatol Res Pract; 2016; 2016():4060673. PubMed ID: 27143961
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multicentre open-label study of apremilast in palmoplantar pustulosis (APLANTUS).
    Wilsmann-Theis D; Kromer C; Gerdes S; Linker C; Magnolo N; Sabat R; Reich K; Mössner R
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):2045-2050. PubMed ID: 34077577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria.
    Marzano AV; Ishak RS; Saibeni S; Crosti C; Meroni PL; Cugno M
    Clin Rev Allergy Immunol; 2013 Oct; 45(2):202-10. PubMed ID: 23334898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin-19 Levels Are Increased in Palmoplantar Pustulosis and Reduced following Apremilast Treatment.
    Wolk K; Wilsmann-Theis D; Witte K; Brembach TC; Kromer C; Gerdes S; Ghoreschi K; Reich K; Mössner R; Sabat R
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne.
    Vinkel C; Thomsen SF
    Int J Dermatol; 2017 Aug; 56(8):811-818. PubMed ID: 28345207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple Facial Lesions of Recalcitrant Pyoderma Gangrenosum Successfully Treated with Adalimumab.
    Kleinfelder RE; Hin N; Cubelli S; Snyder A; Kerdel F; Glick B
    J Clin Aesthet Dermatol; 2019 May; 12(5):28-32. PubMed ID: 31320974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adalimumab in the management of palmoplantar psoriasis.
    Ghate JV; Alspaugh CD
    Dermatol Online J; 2009 Jul; 15(7):15. PubMed ID: 19903443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin (IL)-8 and IL-36γ but not IL-36Ra are related to acrosyringia in pustule formation associated with palmoplantar pustulosis.
    Xiaoling Y; Chao W; Wenming W; Feng L; Hongzhong J
    Clin Exp Dermatol; 2019 Jan; 44(1):52-57. PubMed ID: 29896852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome.
    Marzano AV; Fanoni D; Antiga E; Quaglino P; Caproni M; Crosti C; Meroni PL; Cugno M
    Clin Exp Immunol; 2014 Oct; 178(1):48-56. PubMed ID: 24903614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subcorneal pustulosis and Pyoderma gangrenosum associated with a biclonal gammopathy.
    Puechguiral-Renaud I; Carpentier O; Piette F; Delaporte E
    Eur J Dermatol; 2006; 16(6):687-90. PubMed ID: 17229613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Neutrophilic dermatosis of the hands].
    Brajon D; Cuny JF; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2011 Oct; 138(10):673-6. PubMed ID: 21978504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pyoderma Gangrenosum with Splenic Abscess- A Rare Association.
    Bansal A; Singla A; Singh A; Kaur S
    Indian Dermatol Online J; 2022; 13(2):244-247. PubMed ID: 35287426
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoinflammatory pustular neutrophilic diseases.
    Naik HB; Cowen EW
    Dermatol Clin; 2013 Jul; 31(3):405-25. PubMed ID: 23827244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single-cell analysis implicates T
    McCluskey D; Benzian-Olsson N; Mahil SK; Hassi NK; Wohnhaas CT; ; Burden AD; Griffiths CEM; Ingram JR; Levell NJ; Parslew R; Pink AE; Reynolds NJ; Warren RB; Visvanathan S; Baum P; Barker JN; Smith CH; Capon F
    J Allergy Clin Immunol; 2022 Oct; 150(4):882-893. PubMed ID: 35568077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Possible Efficacy of Vedolizumab, an Anti-α4β7 Integrin Antibody, in Palmoplantar Pustulosis.
    Terui H; Moroi R; Masamune A; Aiba S; Yamasaki K
    Case Rep Dermatol; 2023; 15(1):22-25. PubMed ID: 36726801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pustulosis palmoplantaris is a disease distinct from psoriasis.
    de Waal AC; van de Kerkhof PC
    J Dermatolog Treat; 2011 Apr; 22(2):102-5. PubMed ID: 20687846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: Two birds with one stone.
    Zold E; Nagy A; Devenyi K; Zeher M; Barta Z
    World J Gastroenterol; 2009 May; 15(18):2293-5. PubMed ID: 19437575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.